Patrys Ltd

PATLF:OTCPK
RT Quote | Exchange | USD
Last | EST
UNCH (UNCH)
52 week range
0.00 - 0.00

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close-
  • 52 Week High0.00
  • 52 Week High Date-
  • 52 Week Low0.00
  • 52 Week Low Date-
  • Market Cap20.79M
  • Shares Out1,078.65M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Patrys Ltd News

There is no recent news for this security.

Latest PATLF News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Patrys Limited is engaged in the commercialization of its technologies to develop natural human antibody-based therapeutic products for the treatment of cancer. The Company is engaged in conducting research and development activities in the biopharmaceutical sector. The Company's products include PAT-SM6, PAT-LM1 and PAT-SC1. PAT-SM6 is a natural human antibody that binds to multiple types of cancer, including solid tumors, such as melanoma, breast, colon and pancreatic, as...
John Read
Non-Executive Chairman
James Campbell Ph.D.
Chief Executive Officer
Address
C:/ Leydin Freyer
Australia, L 4 100 Albert Rd
South Melbourne, VIC
3205
Australia